Staphylococcus Aureus Bacteremia (SAB) – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2023 To 2033
_page-0001.jpg)
Staphylococcus aureus bacteremia (SAB) is a severe bloodstream infection linked to significant illness and death. It leads to various complications, such as infective endocarditis, device-related infections, osteoarticular metastases, pleuropulmonary issues, and recurrent infections. Initially, SAB was categorized into healthcare-associated and community-acquired types. However, with advancements in molecular differentiation and understanding, a new classification emerged: healthcare-associated community-onset. Presently, SAB is categorized into three groups: community-acquired, healthcare-associated community-onset, and healthcare-associated hospital-onset. Community-acquired SAB pertains to individuals without prior healthcare contact, including injection drug users and those with spontaneous osteoarticular infections. These cases often present with multiple complications like endocarditis, renal failure, shock, respiratory distress, or disseminated intravascular coagulation....